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HerpesvirusThe IR3 transcript of equine herpesvirus-1 (EHV-1) harbors 117 nts antisense to the immediate-early (IE)
mRNA, suggesting it plays a regulatory role. Here, we show that the IR3 transcript downregulates IE gene
expression and that the absence of IR3 expression altered EHV-1 biological properties and virulence in mice.
Reporter assays revealed that the IR3/IE overlapping sequences [IR3(+226/+342)] and an additional IR3
(+343/+433) region are necessary for the IR3 RNA to downregulate IE expression. Experiments with the
ΔIR3 EHV-1 showed that the IR3 gene is dispensable for EHV-1 replication. Protein expression of the IE and
representative EHV-1 genes was increased in cells infected with ΔIR3 EHV-1 as compared to that of cells
infected with wt EHV-1. The ΔIR3 EHV-1 exhibited increased virulence in mice as compared to the parent
virus. The ﬁnding that the IR3 transcript affects IE gene expression extends the role of RNA as a regulatory
molecule in alphaherpesvirus infection..
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EHV-1 is a member of genus Varicellovirus, subfamily Alphaherpes-
virinae, and its genome of 155 kbp is comprised of a unique long (UL)
region and a short (S) region that is comprised of a unique segment (Us)
bracketed by identical diploid internal and terminal repeat (IR and TR)
sequences (Henry et al., 1981; Telford et al., 1992). As is the case with
other alphaherpesviruses, the regulated expression of EHV-1 genes
occurs in a program of immediate-early, early, and late stages (Caugh-
man et al., 1985; Gray et al., 1987). During productive viral replication,
the sole IE gene is trans-activated by the multi-functional virion-
associated ETIF protein (ETIFP) (Elliott, 1994; Elliott and O'Hare, 1995;
von Einem et al., 2006) to generate the IE protein (IEP) that trans-
activates early and some late viral genes (Smith et al., 1992, 1994; Kim
et al., 1997; Garko-Buczynski et al., 1998) and represses its own
expression (Kim et al., 1995). The IEP interacts with early viral
regulatory proteins such as the IR4 protein (IR4P), EICP0 protein
(EICP0P) and UL5 protein (UL5P), and these protein complexes
synergistically trans-activate EHV-1 genes (Smith et al., 1993; Kim
et al., 1997; Derbigny et al., 2000, 2002; Albrecht et al., 2004, 2005).
Recent studies showed that the early IR2 protein (IR2P) encodedwithin
the IE gene functions as a negative regulatory protein (Kim et al., 2006).
In addition, the EHV-1 unique IR3 gene was predicted to be a potentialseventh regulatory gene. Previous studies showed that the IR3 gene
generates a 1 kb transcript antisense to the5′untranslated region (UTR)
of the IEmRNA, such that 117 nts of the IR3 transcript overlap the 5′UTR
of the IE mRNA (Holden et al., 1992). These data also tentatively
identiﬁed a TATA box, a 5′UTR, an open reading frame (ORF), and a poly
(A) signal. Recently, we revealed that the TATA box is essential for IR3
promoter activation, and that the IEP trans-activates the IR3promoter by
direct binding to the IR3 promoter region and acts synergistically with
the EICP0 and IR4 proteins to increase IR3 promoter activity (Ahn et al.,
2007). Additionally, an IR3 protein (IR3P) was only detected as an
in vitro transcription/translation product, but not in EHV-1 infected or
IR3 expression vector transfected cells, raising the possibility that the
IR3 transcript is a non-coding RNA. The observation that the IR3
transcript harbors 117 nts antisense to the 5′UTR (untranslated region)
of the IE mRNA suggests that the IR3 transcript may affect IE gene
expression in a RNA–RNA fashion. Here, we show that the non-coding
IR3 transcript downregulates IE gene expression as a regulatory RNA
molecule, and thatΔIR3EHV-1possesses altered biological properties in
cell culture and in the EHV-1 mouse model.
Results
IR3(+226/+433) of the IR3 transcript is essential to downregulate IE
gene expression
The non-coding transcript of the IR3 gene that lies antisense to the
IE gene harbors 117 nts overlapping the 5′UTR of the IEmRNA (Fig. 1A;
Fig. 1. Reporter assays to test IR3 transcript sequences for the ability to downregulate luciferase gene expression controlled by IE gene promoter sequences. (A). Location of IR3 and IE
transcripts, and the IE reporter vector. The IE promoter region harboring the IE 5'UTRwas cloned into pGL3-Basic (Promega). Tci, transcription initiation site. “+” and “v” line indicate
nt distance from the transcript initiation site and IE intron region, respectively. (B) The different regions of the IR3 transcript cloned into pSPORT1 as effector vector; + indicates
downregulation of the luciferase IE reporter vector by IR3 effector vectors. The different regions of IR3 transcript were cloned into pSPORT1 (Gibco, BRL), such that expression of IR3
transcript was under the control of SV40 promoter. “+” within parenthesis indicates nucleotide distances from IR3 transcript initiation site.
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hypothesize that the IR3 transcript may affect IE gene expression in a
RNA–RNA fashion. To determine whether the IR3 transcript down-
regulates IE gene expression, we applied a luciferase reporter system.
As shown in Fig. 1, the IE promoter region harboring the IE 5′UTR was
cloned into the pGL3-Basic plasmid (Promega, Madison, WI) as a
reporter vector [pIE(−993/+627-luc)], such that the luciferase gene
was under the control of the IE promoter and IE 5′UTR (Fig. 1A), and
different regions of the IR3 transcript were cloned into the pSVSPORT1
plasmid (Gibco, BRL, Gaithersburg, MD) under the control of the SV40
promoter as the effecter vectors (Fig. 1B). Cotransfection assays
showed that effector vectors [pIR3(+1/+443) and pIR3(+1/+728)]
harboring the IR3/IE overlapping sequences downregulated expres-
sion of the luciferase gene from the reporter vector in a dose de-
pendent manner, but effector vector pIR3(+444/+728) lacking the
IR3/IE overlapping sequences did not affect the expression of
the luciferase gene (Fig. 2A). This observation suggested that the IR3
(+1/+443) region harboring 117 nts of IR3 transcript [IR3(+226/
+342)] antisense to 5′UTR of IE mRNA is responsible for the down-
regulation of the IE gene. To examine whether IR3(+226/+342)
complementary to the IE 5′UTR are the only sequences responsible for
luciferase gene downregulation, we dissected the IR3(+1/+443)
region, cloned these sequences into the pSVSPORT1 vector (Fig. 1B),
and then performed cotransfection assays using the pIE(−993/+627-
luc) reporter vector. Effector vectors pIR3(+1/+226) and pIR3
(+343/+443) that lack the IR3/IE overlapping sequences did not
downregulate luciferase gene expression, possibly due to the lack of
sequences antisense to IE mRNA. Next, we tested pIR3(+1/+284)
that contains 59 nts of the 5′ IR3 transcript within the 117 nts IR3/IE
overlapping sequences, pIR3(+226/+343) that contains the entireIR3/IE overlapping sequences, and pIR3(+285/+443) that contains
58 nts of the 3′ IR3 transcript within the IR3/IE overlapping sequences
as effector vectors. None of these three effector vectors affected
luciferase gene expression (Fig. 2B). However, expression of pIR3
(+226/+443) that contains both the entire IR3/IE overlapping
sequences [IR3(+226/+343)] and additional IR3 transcript
sequences [IR3(+344/+443)] lacking any of the IR3/IE overlapping
sequence led to the downregulation of luciferase gene expression
(Fig. 2B). To examinewhich sequences within [IR3(+344/+443)] are
essential for the regulatory function of the IR3 transcript, pSVIR3
(+226/+403) and pSVIR3(+226/+433) were assayed in the
luciferase reporter assay. Expression of IR3(+226/+433) and the
positive control IR3(+1/+443) downregulated luciferase gene expres-
sion from the reporter vector, but expression of the reporter luciferase
gene was not affected by IR3(+226/+403) or the negative control IR3
(+444/+728) transcript (Fig. 2C).
The IR3 gene is dispensable for viral replication
Downregulation of IE gene expression by the IR3 RNA molecule
suggests that the absence of expression of the IR3 transcript may
affect the biological properties of EHV-1. To examine this hypothesis,
ΔIR3 EHV-1 was constructed by using BAC technology (Rudolph et al.,
2002) as described in Materials and methods. The EHV-1 IR3 gene lies
antisense to the sole IE gene and overlaps sequences within the IE
promoter region (Fig. 1A; Holden et al., 1992). Therefore, deletion of
the entire IR3 gene would disrupt the IE promoter and would be lethal
because the IE gene is essential for EHV-1 replication (Garko-
Buczynski et al., 1998). As an alternative approach, the entire 371 nt
IE intron, in which the IR3 TATA box sequence and IEP binding sites
Fig. 2. Reporter assays to identify IR3 transcript sequences that downregulate the expression of the luciferase gene controlled by IE promoter sequences. Cotransfection assays were
performed by using 1 pM of the pIE(−993/+627)-Luc reporter vector and different concentrations of effector vectors expressing regions of the IR3 transcript as described in
Materials and methods. Error bars represent standard deviations. (A) Luciferase reporter assays using effector vectors [pSVIR3(+1/+728), pSVIR3(+1/+443) and pSVIR3(+444/
+728)]. (B) Luciferase reporter assays using effector vectors [pSVIR3(+1/+226), pSVIR3(+226/+443), pSVIR3(+226/+343), pSVIR3(+343/+443), pSVIR3(+1/+284), and
pSVIR3(+284/+443) and]. (C) Luciferase reporter assays using effector vectors [pSVIR3(+226/+403) and pSVIR3(+226/+433)]. pSVIR3(+1/+443) and pSVIR3(+444/+728)
were used as positive and negative control effector vectors, respectively.
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was replaced with a kanR or zeoR marker without removing the
authentic IE splice donor and acceptor site sequences. This approach
suggests that the presence of a marker within the IE intron sequence
would not affect IE gene expression because the transcript of the
marker would be spliced out as an intron from the primary IE mRNA.
Insertion of the kanR or zeoR markers was conﬁrmed by PCR
ampliﬁcation of marker ﬂanking regions (Fig. 3A) and DNA sequence
analysis (data not shown). Primer sets speciﬁc for the marker ﬂanking
regions ampliﬁed the expected size of PCR product from pΔIR3 EHV-1
BAC (Fig. 3A, lanes 1, 3, 5 and 7), but not from the parent pRacL11 EHV-
1 BAC (Fig. 3A, lanes 2, 4, 6 and 8). BamHI digestion patternswere used
to examine the insertion of markers into pRacL11 EHV-1 BAC and
showed that two different fragments were observed from pΔIR3 EHV-
1 BAC (Fig. 3B, lane 2 indicated as arrows). Additionally, the presence
of the two markers in pΔIR3 EHV-1 BAC was demonstrated by a
southern blot assay using BamHI digested pΔIR3 EHV-1 BAC and a
probe speciﬁc for the zeoR (Fig. 3C) or kanR (Fig. 3D) marker. Each
radiolabeled probe bound to one fragment (Fig. 3C, lane 2, and Fig. 3D,
lane 2), but did not bind to any BamHI digested DNA fragments of
pRacL11 EHV-1 BAC (Fig. 3C, lane 1, and Fig. 3D, lane 1). Once insertion
of markers into pRacL11 EHV-1 BAC was conﬁrmed, ΔIR3 EHV-1 was
generated from pΔIR3 EHV-1 BAC by cotransfection of pΔIR3 EHV-1
BAC and the DNA fragment harboring the Us4 gene into RK13 cells as
described in Materials and methods. To conﬁrm that the ΔIR3 EHV-1
does not express the IR3 transcript, northern blot analysis was
performed using total RNA of ΔIR3 EHV-1 infected RK13 cells and a
probe speciﬁc for the IR3 transcript. The IR3 transcript was detected in
RK13 cells infectedwith RacL11 EHV-1 (Fig. 3E, lane 3), but not in RK13
cells infected with ΔIR3 EHV-1 (Fig. 3E, lane 2). As a positive control,the IR5 transcript was detected by the IR5 gene-speciﬁc probe in RK13
cells infected with ΔIR3 EHV-1 and RacL11 EHV-1. These results
indicate that ΔIR3 EHV-1 does not express the IR3 transcript and that
the IR3 gene is dispensable for EHV-1 replication. To construct the IR3
rescued EHV-1, galK BAC technology was performed as described in
Materials and methods. First, replacement of the kanR marker with
galK marker was conﬁrmed by the PCR ampliﬁcation of galK marker
ﬂanking regions. Left and right primer sets speciﬁc to the galK marker
ﬂanking sequences detected the expected sizes of PCR amplicons from
pΔIR3 zeo galK EHV-1 (Fig. 3G, lanes 1 and 3), but not frompΔIR3 EHV-
1 (Fig. 3G, lanes 2 and 4). Next, galK and zeoR markers were replaced
with the IE intron containing EHV-1 deletion sequences by using galK
counter selection. The replacement was selected by the PCR ampliﬁ-
cation of IE intron spanning sequences. The primer set speciﬁc to the IE
intron spanning sequences detected a PCR amplicon of the expected
size from pIR3R EHV-1 (Fig. 3H, lane 1), and two PCR amplicons of the
expected sizes frompΔIR3 zeo galK EHV-1 (Fig. 3H, lane 2) followedby
the sequence analysis of the PCR amplicons. Complete replacement of
the twomarkerswith native IE intron sequenceswas conﬁrmed by the
PCR ampliﬁcation using the galK and zeoR marker ﬂanking sequence
speciﬁc primer sets. The galK marker left and right ﬂanking sequence
speciﬁc primer sets detected PCR amplicons of the expected sizes
frompΔIR3 zeo galK EHV-1, respectively (Fig. 3I, lanes 1 and3), but not
from pIR3R EHV-1 (Fig. 3I, lanes 2 and 4). In addition, the zeoR marker
left and right ﬂanking sequence speciﬁc primer sets detected PCR
amplicons of the expected sizes from pΔIR3 zeo galK EHV-1,
respectively (Fig. 3I, lanes 5 and 8), but not from pIR3R EHV-1
(Fig. 3I, lanes 6 and 8), indicating that the IE intron deletion sequences
were completely restored.Once IR3REHV-1was generated frompIR3R
EHV-1 as described above, the protein expression of RacL11 EHV-1 and
Fig. 3. Insertion of zeoR and kanR markers into the EHV-1 genome, and conﬁrmation that ΔIR3 EHV-1 lacks expression of the IR3 transcript. PCR, BamHI digestion, northern blot, and
southern blot analyses were performed as described in Materials and methods. (A) PCR ampliﬁcation of marker ﬂanking sequences of pΔIR3 EHV-1. pΔIR3 EHV-1 template (lanes 1,
3, 5, and 7). pRacL11 EHV-1 template (lanes 2, 4, 6, and 8). KanR left ﬂanking region ampliﬁcation primer set (lanes 1 and 2). KanR right ﬂanking region ampliﬁcation primer set (lanes
3 and 4). ZeoR left ﬂanking region ampliﬁcation primer set (lanes 5 and 6). ZeoR right ﬂanking region ampliﬁcation primer set (lanes 7 and 8). “M” is DNA size marker. (B) BamHI
digestion pattern of pΔIR3 EHV-1 BAC DNA. Lanes 1 and 2 represent pRacL11 EHV-1 BAC and pΔIR3 EHV-1 BAC, respectively. (C and D) Southern blot analyses of BamHI digested
pΔIR3 EHV-1 BAC DNA by using probes speciﬁc for zeoR (C) and kanR (D) genes. Lanes 1 and 2 indicate pRacL11 EHV-1 and pΔIR3 EHV-1 BAC DNA, respectively. (E and F) Northern
blot analysis to conﬁrm the absence of the IR3 transcript in ΔIR3 EHV-1 infected cells by using a probe speciﬁc for the IR3 transcript (E), and a probe speciﬁc to IR5 transcript as a
positive control (F). (G, H and I) The PCR ampliﬁcations of marker ﬂanking sequences to conﬁrm 1). the insertion of galKmarker by using galKmarker left and right ﬂanking sequence
speciﬁc primer sets (G), 2). the removal of galK and zeoR markers by using IE intron ﬂanking sequence speciﬁc primer set (H) and 3). the presence of galK and zeoR markers by using
primer sets speciﬁc to galK and zeoR marker ﬂanking sequences (I). (J) Comparison of the IE protein expression from RK13 cells infected with RacL11 EHV-1 and IR3R EHV-1 (at moi
of 10) during immediate-early, early, and late times of EHV-1 replication.
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secondary mutation(s) of ΔIR3 EHV-1. IE protein expression levels of
the RacL11 EHV-1 and IR3R EHV-1 were identical during immediate-
early, early, and late time of EHV-1 replication (Fig. 3J), indicating that
there was no secondary mutation in the ΔIR3 EHV-1 mutant.
Serial passage of ΔIR3 EHV-1 in permissive cells leads to the sequence
recombination between IR and TR sequences
The IR and TR sequences of the EHV-1 short genomic region harbor
identical sequences (Henry et al., 1981; Telford et al., 1992). Previously,
we observed that deletion of one gene within the IR or TR region is
recovered by identical sequences from the other inverted repeat during
reproductive replication in permissive cells, such that both IR and TR
sequences become identical (data not shown). In addition, homologous
genomic recombination between two different viral species has been
described for alphaherpesviruses (Meurens et al., 2004; Umene, 1985).
These observations led us to examine whether the IR and TR segments
harboring each of the two different marker genes, respectively, become
identical diploid sequences during the serial passages of the ΔIR3
mutant virus in permissive cells. First, the presence of marker genes in
the ΔIR3 EHV-1 was examined by PCR analysis using DNA from ΔIR3
EHV-1 infected RK13 cells, and primer sets to detect the kanR and zeoRmarkers as described in Materials and methods. Interestingly, the
expected size PCR product was ampliﬁed from primer sets to detect the
zeoR marker (Fig. 4A, lanes 3 and 4), but not from primer sets to detect
the kanR marker (Fig. 4A, lanes 1 and 2). Further, the presence of the
zeoRmarker and the absence of the kanRmarker were conﬁrmed by dot
blot hybridization analysis with a probe speciﬁc for the kanR or zeoR
marker as described in Materials and methods. The DNA probe speciﬁc
for the kanR marker (Fig. 4B) bound to only pΔIR3 EHV-1 BAC DNA
(no. 3), but not to the empty spot (no. 1), pRacL11 EHV-1 BAC DNA
(no. 2), RK13 cell DNA (no. 4), RacL11 EHV-1 infected RK13DNA (no. 5)
orΔIR3 EHV-1 infected RK13 cell DNA (no. 6). The probe speciﬁc to zeoR
marker (Fig. 4C) to determine if the zeoR marker was retained in the
ΔIR3 EHV-1 genome bound to both pΔIR3 EHV-1 BAC DNA (no. 3) and
also toDNAofΔIR3 EHV-1 infectedRK13 cells (no. 6).However, the zeoR
probe (Fig. 4B) did not bind to control emptyDNA (no. 1), pRacL11EHV-
1 BAC DNA (no. 2), RK13 cell DNA (no. 4), or DNA of RacL11 EHV-1
infected RK13 cells (no. 5).
ΔIR3 EHV-1 has a larger plaque size, but exhibits host cell tropism and
growth kinetics in RK13 cells similar to those of the parent virus
Next, experiments were carried out to determine whether the
absence of expression of the IR3 transcript affected the biological
Fig. 4. The kanRmarker was replacedwith the zeoRmarker during serial passage ofΔIR3
EHV-1. PCR and dot blot hybridization analyses were performed as described in
Materials and methods. (A) PCR ampliﬁcation of ﬂanking regions of markers inserted
into ΔIR3 EHV-1 genome. ΔIR3 EHV-1 infected RK13 DNA was used as template. KanR
left ﬂanking region ampliﬁcation primer set (lane 1). KanR right ﬂanking region
ampliﬁcation primer set (lane 2). ZeoR left ﬂanking region ampliﬁcation primer set
(lane 3). ZeoR right ﬂanking region ampliﬁcation primer set (lane 4). “M” is DNA size
marker. (B and C) Dot blot hybridization analyses with probes speciﬁc for the kanR and
zeoR markers, respectively. Lanes 1–6 represent mock DNA, pRacL11 EHV-1 DNA, pΔIR3
EHV-1 DNA, RK13DNA, RacL11 EHV-1 infected RK13 DNA, andΔIR3 EHV-1 infected RK13
DNA, respectively.
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plaque size of ΔIR3 EHV-1 was increased by more than 50% compared
to those of RacL11 EHV-1 and IR3R EHV-1 (Fig. 5A and B) and that the
change in plaque size was statistically signiﬁcant (p=0.0006). As a
next step, we examined the cell tropism and growth kinetics of ΔIR3Fig. 5. Comparison of plaque size of RacL11 EHV-1, ΔIR3 EHV-1 and IR3R EHV-1 in RK13 cells
IR3R EHV-1. (B) Comparison of plaque size in RK13 cells infected with RacL11 EHV-1, ΔIR3 EH
program; the two-tailed Student's t test was used for data analysis. Error bars indicate stanEHV-1 as compared to those of the parent RacL11 EHV-1 (Fig. 6A). The
ΔIR3 EHV-1 like the parent virus was capable of replication in cells of
mouse, rabbit, equine, monkey, and human origin (Fig. 6A), and IR3R
EHV-1 also exhibited the cell tropism identical to that of RacL11 and
ΔIR3 EHV-1 (data not shown). Both RacL11 andΔIR3 EHV-1 replicated
tomuch greater titers in the equine NBL-6, rabbit RK13, andmouse LM
cells as compared to titers achieved in human HeLa and monkey Vero
cells. In addition, RacL11 EHV-1 and ΔIR3 EHV-1 exhibited virtually
identical growth kinetics in RK13 cells infected at a multiplicity of
infection of both 5 (Fig. 6B) and 0.1 (Fig. 6C) pfu/cell.
ΔIR3 EHV-1 showed increased protein expression of EHV-1 representative
genes in RK13 cells
The observation that the IR3 transcript downregulated expression of
the luciferase gene under the control of the IE 5′UTR and promoter
suggests that the absence of IR3 transcript may affect expression of the
IE gene in infected cells. To examine whether any consequences of the
lack of IR3 gene expression occur in EHV-1 gene programming,
expression of the sole IE gene and representative early and late genes
wasmonitored at different time points after infection of RK13 cells. The
IEP was detected at 3 h post infection (hpi) in both RacL11 EHV-1 and
ΔIR3 EHV-1 infected RK13 cells (Fig. 7A, lanes 3 and 4), and IEP levels in
ΔIR3 EHV-1 infected cells were slightly higher during early and late
stages of replication than those of RacL11 EHV-1 infected cells (Fig. 7A,
lanes 5–8). Protein expression from the IR4 early gene was barely
detected in RK13 cells infected with RacL11 or ΔIR3 EHV-1 at 3 hpi
(Fig. 7B, lanes 3 and 4), and protein expression levels of ΔIR3 EHV-1
infected cells were higher than those of RacL11 EHV-1 infected cells
during early and late time points of replication (Fig. 7B, lanes 5–8). As
another early gene product, the UL5P was observed at 3 hpi, and UL5P
expression levels in RK13 cells infected with ΔIR3 EHV-1 were higher
than those of RacL11 EHV-1 infected cells through all stages of
replication (Fig. 7C, lanes 3–8). Protein expression of EICP0, a potent
early regulatory gene, was barely detected at 3 hpi (Fig. 7D, lanes 3 and
4), and protein expression levelswere higher inRK13 cells infectedwith
ΔIR3 EHV-1 than in RK13 cells infected with RacL11 EHV-1 during early
and late stages of replication (Fig. 7D, lanes 5–8). As expected, the late
gene product glycoprotein D (gDP) was ﬁrst detected at late times (12. (A) Morphology of plaques in RK13 cells infected with RacL11 EHV-1, ΔIR3 EHV-1 and
V-1 and IR3R EHV-1. Relative plaque sizes were measured by using the ImageJ software
dard deviation.
Fig. 6. Cell tropism and growth kinetics. (A) Cell tropism and viral titers of ΔIR3 EHV-1
and RacL11 EHV-1 in mouse LM, rabbit RK13, equine NBL-6, simian Vero, and human
HeLa cells. Cell monolayers were infected at a moi of 5 with ΔIR3 EHV-1 or RacL11 EHV-
1, harvested at 72hpi, and titered as described inMaterials andmethods.White and gray
bars indicate RacL11 EHV-1 and ΔIR3 EHV-1 titers, respectively. (B) Viral growth
kinetics of RacL11 EHV-1 andΔIR3 EHV-1 in RK13 cells infected at amoi of 5. (C) Growth
kinetics of RacL11 EHV-1 and ΔIR3 EHV-1 in RK13 cells infected at a moi of 0.1. Cell
monolayers were infected with RacL11 EHV-1 or ΔIR3 EHV-1, and aliquots were
harvested at designated time points. Virus was titered as described in Materials and
methods. Error bars indicate standard deviations.
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the amount of gDP in ΔIR3 EHV-1 infected RK13 cells was greater than
that in RK13 cells infected with RacL11 EHV-1 (Fig. 7E, lanes 7 and 8).
The multiple repeat experiments also showed identical results in the
protein expression. In addition, the difference of the protein expression
between parent virus and mutant virus infected RK13 cells was further
determined by using ImageJ software program. Comparison of protein
expression of EHV-1 representative genes showed that EHV-1 protein
expression levels fromΔIR3 EHV-1 infectedRK13 cellswere higher than
those from RacL11 EHV-1 infected RK13 cells (Fig. 7F).
ΔIR3 EHV-1 retained full virulence in the CBA mouse model
To examine the possibility that the absence of expression of the IR3
transcript affected EHV-1 virulence, animal experiments in the well-characterized CBA mouse model were performed as described in
Materials and methods. As shown in Fig. 8A, body weight of mice
infected with ΔIR3 EHV-1, IR3R EHV-1, or RacL11 EHV-1 was
signiﬁcantly decreased compared to those of control group mice (all
p valuesb0.001). In addition, the correlation of the body weight loss
among mouse groups infected with ΔIR3 EHV-1, IR3R EHV-1, or
RacL11 EHV-1 was signiﬁcant (p values b 0.01), indicating there was
no difference of body weight loss among mouse groups infected with
ΔIR3 EHV-1, IR3R EHV-1, or RacL11 EHV-1. However, a plot of the
percent survival in Fig. 8B showed that there was a signiﬁcant
difference (p=0.003) between the RacL11 EHV-1 and ΔIR3 EHV-1,
and there was no signiﬁcant difference between the RacL11 EHV-1
and IR3R EHV-1 (p=0.14), indicating an increase in the virulence of
the mutant virus as compared to that of the parent RacL11 EHV-1.
To determine whether the early death of mice infected with ΔIR3
EHV-1 was related to viral load, we examined the viral titers of lungs
from EHV-1 infected live (Fig. 8C) and dead (Fig. 8D) mice. Viral titers
in the lungs of live mice were the highest at early dpi and decreased at
later dpi (Fig. 8C). Decrease of the viral load in mice infected with
RacL11, IR3R, orΔIR3 EHV-1 swas similar at each dpi. Assay of the viral
titers in lungs of deadmice (Fig. 8D) revealed that viral lung titers also
decreased as time progressed. However, the lung viral titers of allΔIR3
EHV-1 infected mice that succumbed early to infection were at the
peak titer at these early times, suggesting that the IR3 mutant virus is
capable of rapid and efﬁcient replication in the murine respiratory
tract.
Discussion
Here, we presented ﬁndings that the non-coding IR3 transcript has
a regulatory function in EHV-1 replication and its absence affects EHV-
1 biological properties and virulence in a mouse model. Our
observation that part of the IR3 transcript is antisense to IE mRNA
led us to examine the possibility that the IR3 transcriptmay regulate IE
gene expression as a RNAmolecule. Cotransfection assays showed that
the IR3 transcript [(IR3(+1/+443)] harboring IR3/IE overlapping
sequences downregulated IE gene expression in a dose dependent
manner. Additional experiments revealed that in addition to the IR3/IE
overlapping sequences at [IR3(+226/+342), IR3 sequences +344/
+433 outside the antisense region are essential for IR3 RNA to
downregulate IE gene expression. Also, the expression of the IR3
transcript from all IR3 effector vectors in transfected RK13 cells at 12
hpt was conﬁrmed by RT-PCR analyses (data not shown). Thus, the
lack of the IE gene downregulation by some of the IR3 effector vectors
was not due to the lack of its IR3 transcript expression. Overall, these
results indicate that EHV-1 gene expression is inﬂuenced not only by
the six known viral regulatory proteins, but also by EHV-1 encoded
RNA as a regulatory molecule.
Next, we employed a genetic approach to examine the biological
functions of the IR3 transcript andgenerated a virusmutant that lacked
the ability to express the IR3 transcript. Since deletion of the entire IR3
gene sequence would remove the promoter region of the IE gene (see
Fig. 1) that is essential for EHV-1 replication (Garko-Buczynski et al.,
1998), an alternative approach to overcome this obstaclewas required.
To this end, 371 nts of the IE intron (Harty et al., 1989; Grundy et al.,
1989, Fig. 1A) that harbors the IR3 TATA box essential for IR3 promoter
activity (Ahn et al., 2007) were replaced with a kanR or zeoR maker by
using BAC technology. The marker within the IE intron sequence
would not affect IE gene expression because the transcript of the
marker would be spliced out as an intron of the primary IEmRNA. As
expected, the resulting ΔIR3 EHV-1 generated from the pΔIR3 EHV-1
BAC was replication competent, indicating that the IR3 gene as a
negative regulator is dispensable for EHV-1 replication.
In alphaherpesviruses, homologous genomic recombination be-
tween distinguishable strains has been described for herpes simplex
viruses 1 and 2 (Umene, 1985), pseudorabies virus (Dangler et al.,
Fig. 7. Expression levels of EHV-1 IE, early, and late proteins. RK13 cells infected with ΔIR3 EHV-1 or RacL11 EHV-1 at a moi of 10 were harvested at 3, 6, and 12 hpi, and protein
expression was examined by western blot analysis as described in Materials and methods. Detection of the (A) immediate-early protein, (B) early IR4 protein, (C) early UL5 protein,
(D) early EICP0 protein, and (E) late glycoprotein. (F) Relative protein density of EHV-1 representative genes in RacL11 and ΔIR3 EHV-1 infected RK13 cells. Protein density was
compared by using the ImageJ software program (http://rebweb.nih.gov/ij/). White and gray bars indicate proteins of RK13 cells infected with RacL11 EHV-1 and ΔIR3 EHV-1,
respectively. Relative protein density was the protein density of each protein relative to the amount of that protein in RK13 cells infected with ΔIR3 EHV-1 at 12hpi.
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(Dohner et al., 1988), andbovineherpesviruses 1 and5 (Meurens et al.,
2004). The presence of identical IR and TR sequences in the EHV-1
genome led us to examine whether one marker located within either
the IR or TR of the ΔIR3 EHV-1 genome could be replaced with the
other marker sequence by homologous recombination during serial
passage in permissive cells. Interestingly, this was the case as the kanR
marker was replaced by the zeoR marker sequences, which was
conﬁrmed by PCR ampliﬁcation, sequence analysis, and dot blot
hybridization analyses (Fig. 3). Considering that the ﬂanking
sequences of the two markers within the ΔIR3 EHV-1 genome are
identical and the frequency of homologous genomic recombination
in alphaherpesviruses, it was not surprising that one marker was
replaced with the other marker in permissive RK13 cells. We
hypothesize that this replacement that favored the selection of zeoR
over kanRwas due to the size difference between the two foreign DNA
sequences, about 0.5 kb and 1.5 kb for zeoR and kanR, respectively.
The effect of preventing the expression of the IR3 transcript on
plaque size, cell tropism, growth kinetics, and protein expression
levels of representative genes was examined in cells infected with the
ΔIR3 EHV-1. The increased plaque size of the ΔIR3 EHV-1 was not an
unexpected result because the absence of a negative regulatory
molecule could accelerate the trans-activation of EHV-1 genes, leadingto more rapid virus spread. Also, that the cell tropism of ΔIR3 EHV-1
was identical to that of the RacL11 EHV-1 was not surprising since the
absence of the IR3 transcript was not predicted to prevent the
expression of viral envelope glycoprotein(s) responsible for attach-
ment and penetration and thereby inﬂuence host range. Interestingly,
protein expression levels of representative EHV-1 genes were
increased in ΔIR3 EHV-1 infected cells, and these observations could
be explained by the following facts. The IR3 transcript as a negative
regulator downregulates expression of the IE gene that directly or
indirectly upregulates expression of the EICP0, IR4, UL5 and gD genes.
As a consequence of the lack of IR3 transcript, expression of the IE gene
would be upregulated, and then protein expression of early and late
genes that are trans-activated to a large extent by the IEP would be
increased. The upregulation of the IEPwas not only shown in the RK13
cells as presented in our results, but also observed in the equine origin
NBL-6 cells (data not shown), supporting the role of the IR3 transcript
in the EHV-1 gene expression. In addition, that deletion of an EHV-1
regulatory gene affects expression levels of EHV-1 genes has been
described in EHV-1 mutants such as ΔEICP0 EHV-1 (Yao et al., 2003),
and ΔIR4 EHV-1 (Breitenbach et al., 2009). These observations are
consistent with the suggestion that increased protein expression in
ΔIR3 EHV-1 may be due to the lack of the IR3 transcript that reduces
IEP production, even thoughwe cannot exclude the possibility that the
Fig. 8. Percentage change in body weight of CBA mice infected with mock inoculum, RacL11 EHV-1, and ΔIR3 EHV-1, and EHV-1 titers of mouse lungs. Mice were intranasally
inoculated with sterile medium as control or with 2×106 PFU/mouse of either wt RacL11 EHV-1 or ΔIR3 EHV-1, and total virus was isolated from mouse lungs and titered as
described in Materials and methods. Body weight was measured daily, and the two-tailed Student's t test was used for data analysis to compare body weight between groups. Error
bars indicate standard deviation. (A) Percentage change in body weight of CBA mice infected with ΔIR3 EHV-1 (n=9), IR3R (n=9) or RacL11 EHV-1 (n=9). (B) Percent survival of
the mice infected with RacL11 EHV-1 (n=9), IR3R EHV-1 (n=9), ΔIR3 EHV-1 (n=9), or mock (n=9). (C) Viral titers of lungs of live mice infected with RacL11 EHV-1 (n=3, white
bars), IR3R EHV-1 (n=3, black bars), orΔIR3 EHV-1 (n=3, gray bars) at 2, 3, and 4 dpi. (D) Viral titers of lungs from deadmice infected with RacL11 EHV-1 (white bars), IR3R EHV-1
(black bars) orΔIR3 EHV-1 (gray bars) at 2, 3, 4, 5, and 6 dpi. Each bar indicates the average viral titer of mice succumbed at the same day. The sample number(s) of each bar from at 2
dpi to 6 dpi are n=1 (bar 1), n=4 (bar 2), n=2 (bar 3), n=2 (bar 4), n=3 (bar 5), n=2 (bar 6), n=3 (bar 7), n=1 (bar 8), n=2 (bar 9), n=3 (bar 10), and n=1 (bar 11),
respectively.
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infected at amoi of 5 or 0.1, similar growth patternswere observed for
both RacL11 and ΔIR3 EHV-1. These ﬁndings showed that the increase
in the levels of the IEP and representative early and late proteins in
cells infected with the IR3 mutant virus did not result in enhanced
virus growth in cell culture. However, in the CBA mouse model,
intranasal infection with the ΔIR3 EHV-1 resulted in an increase in
virulence as this group of mice succumbed more rapidly to infection
and virus titers in the lung peaked much earlier than was the case for
mice infected with RacL11 EHV-1.
EHV-1 encodes only one immediate-early gene, and its 1487 amino
acid protein product is the major viral regulatory protein that by itself
and in concert with other viral regulatory protein orchestrates the
gene program (O'Callaghan and Osterrieder, 2008). Because of the
importance of the IEP in EHV-1 replication, at least three mechanisms
operate to govern the IE gene: 1. the IEP itself is autoregulatory and is
capable of downregulating the IE gene by binding to a target binding
site that overlaps the transcription start site (Kim et al., 1995); 2. the
early IR2 protein that is generated from an early gene that maps with
the IE gene (Harty and O'Callaghan, 1991) is a major negative
regulatory protein and functions to downregulate IE gene expression
(Kim et al., 2006); and 3. the IR3 transcript harbors sequences
antisense to the IE gene (Holden et al., 1992; Ahn et al., 2007) and as
shown in this study has the ability to affect IE gene expression. The
ﬁndings that expression of the EHV-1 unique IR3 gene is not essential
for viral replication in cell culture and that overall the regulatory IR3
RNA appears to have a modest role in virus growth in cell culture raise
the question of the importance of this gene in EHV-1 infection of its
natural hosts. One possibility that merits consideration is that the IR3regulatory RNAmight contribute to suppression of IE gene expression
in EHV-1 latently infected cells and thus serve a function as a latency-
associated transcript. This possibility and questions about the speciﬁc
mechanism by which IR3 RNA mediates its regulatory function are
topics for ongoing investigations.
Materials and methods
Cell culture
All cell cultures were maintained with Eagle's minimal essential
medium (EMEM) supplemented with 100 units of penicillin/ml,
100 µg of streptomycin/ml, nonessential amino acids, and 5% (or 10%)
fetal bovine serum.
Construction of reporter and effector plasmids for luciferase assays
The PCR products were ampliﬁed using Accuprime pfx polymerase
(Invitrogen, Carlsbad, CA), template plasmid containing IR region
ﬂanking sequences, and primers containing proper restriction enzyme
sites at the 5′ ends. The PCR products were digested with appropriate
restriction enzymes and cloned into proper vectors using standard
cloning methods (Sambrook et al., 1989). All clones were conﬁrmed
by DNA sequence analysis. For the luciferase reporter assay, reporter
and effector vectors were constructed. To generate the reporter
vector, the IE promoter region [IE(+627/−993)] including the IE 5′
UTR was ampliﬁed (primers, 5′ aag gtg ggt acc ggg cat ctc c 3′, 5′ aat
aga tct ggc gtg cta gct ccg gc 3′), and the PCR product thatwas digested
with KpnI and BglII was cloned into pGL3-Basic (Promega) digested
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of the IR3 transcript were PCR-ampliﬁed and cloned into pSVSPORT1
(Gibco, BRL). The PCR product of IR3(+1/+226) (primers, 5′att ggt
acc tcc gcc gag gca gaa gcc g 3′, 5′ taa tct aga caa cgg cca atc aca atc gat
agt gtg 3′), IR3(+1/+284) (primers, 5′att ggt acc tcc gcc gag gca gaa
gcc g 3′, 5′ tta tct aga act gat cgc atc ccg gaa ag 3′), IR3(+1/+443)
(primers, 5′att ggt acc tcc gcc gag gca gaa gcc g 3′, 5′ taa tct aga caa cgg
cca atc aca atc gat agt gtg 3′), IR3(+1/+728) (primers, 5′att ggt acc
tcc gcc gag gca gaa gcc g 3′, 5′ agc tct aga tca cga acc ccg ttg gcg cga cgc
3′), IR3(+226/+343) (primers, 5′ ttt ggt acc ctt acc tcc gca agc cg 3′,
5′ttt tct aga gta gca tcg cgg act aga cac 3′), IR3(+226/+443) (primers,
5′ ttt ggt acc ctt acc tcc gca agc cg 3′, 5′ taa tct aga caa cgg cca atc aca
atc gat agt gtg 3′), IR3(+285/+443) PCR product (primers, 5′ tta ggt
acc agt cct cga agg ctg gct gg 3′, 5′ taa tct aga caa cgg cca atc aca atc gat
agt gtg 3′), IR3(+444/+728) (primers, 5′ tag ggt acc gcg acc atg ggc
ggt ggg cgt gta gcg 3′, 5′ agc tct aga tca cga acc ccg ttg gcg cga cgc 3′),
IR3(+343/+443) (primers, 5′ tat ggt acc gat ggg taa gca aca ggt g 3′,
5′ taa tct aga caa cgg cca atc aca atc gat agt gtg 3′), IR3(+226/+403)
(primers, 5′ ttt ggt acc ctt acc tcc gca agc cg 3′ 5′ ttt tct aga cac tag ggg
gaa ggc 3′), or IR3(+226/+433) (primers, 5′ ttt ggt acc ctt acc tcc gca
agc cg 3′ 5′ ttt tct aga tca caa tcg ata gtg tgg g 3′) was digested with
KpnI and XbaI, and cloned into pSVSPORT1 vector (Gibco, BBL)
digested with KpnI and XbaI. The above cloned plasmids were named
pSVIR3(+1/+226), pSVIR3(+1/+284), pSVIR3(+1/+443), pSVIR3
(+1/+728), pSVIR3(+226/+342), pSVIR3(+226/+443), pSVIR3
(+285/+443), pSVIR3(+444/+728), pSVIR3(+343/+443),
pSVIR3(+226/+403), and pSVIR3(+226/+433), respectively, and
were used as effector vectors in the luciferase reporter assays.
Luciferase reporter assays
The luciferase reporter assay was performed as previously
described (Ahn et al., 2007). Brieﬂy, 80% conﬂuent RK13 cells were
prepared in 24 well plates, and 1 pM of reporter vector [pIE(+627/
−993)-Luc] and different concentration (0–3 pM) of effector vectors
[pSVIR3(+1/+226), pSVIR3(+1/+284), pSVIR3(+1/+443),
pSVIR3(+1/+728), pSVIR3(+226/+343), pSVIR3(+226/+443),
pSVIR3(+343/+443), pSVIR3(+285/+443), pSVIR3(+226/
+403), pSVIR3(+226/+433), and pSVIR3(+444/+728)] were
used. Six microliters of lipofectin (Invitrogen) was mixed with
100 μl of Opti-MEM medium (Gibco, BRL), and incubated for 45 min
at room temperature. The effector and reporter plasmids were mixed
with 100 μl of Opti-MEM medium (Gibco, BRL), and total DNA was
adjusted to the same amount with pSVSPORT1 DNA (Gibco, BRL). The
mixtures were combined and incubated at room temperature for
15 min, and 460 μl of Opti-MEM medium (Gibco, BRL) was added.
One-third of the total mixture was transferred into each of three wells
of 24 well plates of RK13 cell monolayers after washing with serum-
free and antibiotics-free EMEM. At 8 h post transfection (hpt), normal
growthmediumwas added. Luciferase activitywasmeasured at 48 hpt
using a luciferase assay kit (Promega) and POLARstar OPTIMA plate
reader (BMG LABTECH Inc., Burham, NC) according to the manufac-
turer's directions.
RT-PCR assay to verify IR3 RNA synthesis
Each of the effector vectors expressing the IR3 transcript or
portions of this mRNA was transfected into the 80% conﬂuent RK13
cells by using lipofectin (Invitrogen, Carlsbad, CA) according to the
manufacturer's directions. At 12 h post transfection, total RNAs were
isolated by using RNA Bee RNA isolation kit (Tel-Test, Inc., Friend-
wood, TX). The ﬁrst strand cDNA synthesis was performed by using
total RNA template, 10 pM/μ reverse primer, and Superscript III
reverse transcriptase kit (Invitrogen) according to the manufacturer's
directions. The second round DNA ampliﬁcation of the speciﬁc IR3
transcript region was performed by using the Acuprime pfx supermix(Invitrogen), primers speciﬁc to each IR3 transcript region, and 2 μl of
the ﬁrst strand cDNA. Ampliﬁcation of the IR3 transcript region was
visualized on 1% agarose gels containing ethidium bromide.
Generation of ΔIR3 EHV-1 and IR3R EHV-1
To delete the IR3 TATA box sequences, the PCR product of the IE
intron leftﬂanking sequences (primers, 5′ agt tct gca gcc agg aca tgg ctt
cgc gg 3′, 5′ tta tct aga aaa aga tct ata act tcg tat aat gta tgc tat acg aag tta
tgc ttt tcc agg gta gag aag cgg 3′) was digested with PstI and XbaI, and
cloned into pGEM-3Z(+) (Promega) digested with PstI and XbaI
(named pIR3L). The PCR fragment of the IE intron right ﬂanking
sequences (primers, 5′ tta tct aga ata act tcg tat agc ata cat tat acg aag
tta tgg gag ctc tta cct ccg caa gat gct acg atg ggt aag caa cag g 3′, 5′ tgg
acg tgg gtg gaa gga ggg tac cgg3′)was digestedwithXbaI andKpnI, and
cloned into pIR3L digested with XbaI and KpnI (named pIR3L-R). The
PCR product of zeoR (primers, 5′ tta tct aga atc gaa atc tcg tag cac gtg 3′,
5′ gtt aga tct tta gga gct tgt ata tcc att ttc gg 3′) from plasmid pSVZeo2
(Invitrogen)] was digested with BglII and XbaI, and cloned into pIR3L-
R digested with BglII and XbaI (named pIR3LR-zeoR). The PCR product
of kanR (primers, 5′ att aga tct ttt cgg gga aat gtg cg 3′, 5′ tta tct aga aat
ctc gtg atg gca ggt tgg 3′) from plasmid pEGF-N1 (Clontech, Mountain
View, CA) was digested with BglII and XbaI, and cloned into pIR3L-R
digested with BglII and XbaI (named pIR3LR-kanR). The ﬂanking
sequences of both kanR and zeoR markers that were cloned into the
pIR3LR vector included authentic IE splicing donor and acceptor sites.
Deletion of the IE intron to construct theΔIR3 EHV-1was performedby
using BAC technology (Rudolph et al., 2002). First, the DNA fragment
with the kanR gene with ﬂanking sequences of the IE intron was
obtained from pIR3LR-kanR by KpnI and PstI digestion, and was
electroporated into E. coli DY380 containing pRacL11 EHV-1 BAC
(parent EHV-1 BAC) previously grown at 42 °C for 20 min to induce
RED recombinase. Electroporated cultureswere grownat 30 °C on agar
plates containing kanamycin (30 μg/ml) and chloramphenicol (30 μg/
ml), and selected colonies were conﬁrmed by PCR ampliﬁcation of
junctions between the EHV-1 genomic sequences and the antibiotic
resistant marker (primers, 5′ ggc atc aga gca gcc gat tgt ctg ttg tg 3′/5′
tga act tct ggc aga act gcg cca ggt tct gg 3′, 5′ gct atc agg aca tag cgt tgg
cta ccc gtg ata 3′/5′ ttt act cgg tac aac gat tgt gcg tgt gtg cgg 3′) and
sequence analysis (named pΔIR3 kanREHV-1 BAC). The second copy of
the IE intron was deleted in the same manner. The DNA fragment
harboring the zeoR gene with ﬂanking sequence of the IE intron was
obtained from pIR3LR-zeoR by KpnI, ScaI, and PstI digestion, and was
electrophorated into E. coli DY380 containing pΔIR3 kanREHV-1 BAC.
Then, positive colonies were selected on agar plates containing
kanamycin (30 μg/ml), chloramphenicol (30 μg/ml), and zeomycin
(30 μg/ml). Complete replacement of the IE intron with antibiotic
marker genes was conﬁrmed by BamHI restriction digestion, northern
blot analysis using probes speciﬁc for the kanR or zeoRmarker, and PCR
ampliﬁcation of junctions between the EHV-1 genomic sequences and
antibiotic resistant markers (primers, 5′ tcc gac cac tcg gcg tac agc tcg
tcc agg 3′/5′ tga act tct ggc aga act gcg cca ggt tct gg 3′, 5′ tgg acg agc tgt
acg ccg agt ggt cgg 3′/5′ ttt act cgg tac aac gat tgt gcg tgt gtg cgg 3′)
followed by DNA sequence analysis (named pΔIR3 EHV-1 BAC).
To construct IR3 gene rescued (IR3R) EHV-1, galK BAC technology
was used according to the previously described method (Warming
et al., 2005). First, pΔIR3 EHV-1 was transformed into SW106 E. coli,
and galK gene PCR product ﬂanked by kan gene ﬂanking sequences
(primers, 5′ ttt cgg gga aat gtg cgc gga acc cct att tgt tta ttt ttc taa cct
gtt gac aat taa 3′/5′ aat ctc gtg atg gca ggt tgg gcg tcg ctt ggt cgg tca ttt
cga act gtc ctg ctc ctt 3′) was transformed into SW106 E. coli
containing pΔIR3 EHV-1. First, replacement of the kan gene with galK
gene was screened on galK positive agar plate containing chloram-
phenicol and zeocine, and then conﬁrmed by PCR ampliﬁcation of
galK left (primers, 5′ atg atc ccg cag tta cag cct aca aac tgg 3′/5′ tag ctc
cgg ctt cgg ggt cga g 3′) and right (primers, 5′ tga aac atc tgc aac tgc gta
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sequences (named pΔIR3 zeo galK EHV-1). The PCR product harboring
the entire IE intron and its ﬂanking sequences (primers, 5′ tag ctc cgg
ctt cgg ggt cga g 3′/5′ ata tga gag gcg cta ttc ggc atc ccg 3′) was
transformed into SW106 E. coli harboring pΔIR3 zeo galK EHV-1.
Replacement of the galK and zeoR markers with the IE intron
sequences in pΔIR3 zeo galK EHV-1 was screened by galK counter
selection and then conﬁrmed by the PCR ampliﬁcation (primers, 5′ tag
ctc cgg ctt cgg ggt cga g 3′/5′ ata tga gag gcg cta ttc ggc atc ccg 3′) of
the IE intron sequences (named pIR3R EHV-1). In addition, recovery of
the deleted IE intron sequences was conﬁrmed by PCR ampliﬁcation
using galK left (primers, 5′ atg atc ccg cag tta cag cct aca aac tgg 3′/5′
tag ctc cgg ctt cgg ggt cga g 3′) and right (primers, 5′ tga aac atc tgc aac
tgc gta aca aca gct tcg g 3′/5′ ata tga gag gcg cta ttc ggc atc ccg 3′)
ﬂanking sequences, and zeoR left (primers, 5′ tga act tct ggc aga act gcg
cca ggt tct gg 3′/5′ tgg acg agc tgt acg ccg agt ggt cgg 3′) and right
(primers, 5′ ttt act cgg tac aac gat tgt gcg tgt gtg cgg 3′/5′ aag ttc gtg
gac acg acc tcc gac cac tcg 3′) ﬂanking sequences followed by the
sequence analysis of the PCR amplicons.
To generate the ΔIR3 EHV-1 and IR3R EHV-1, puriﬁed pΔIR3 EHV-
1 BAC (or pIR3R EHV-1) and Us4 gene DNA in which the BAC DNA
was inserted were cotransfected into 80% conﬂuent RK13 cells by
using the BD CalPhos Mammalian transfection kit (Clontech)
according to the manufacturer's directions. The supernatant was
harvested at 3 days post transfection and was transferred to plates of
80% conﬂuent RK13 cells followed by low melting agar overlay.
Plaques lacking green ﬂuorescence were selected and puriﬁed by
three rounds of plaque assays (named ΔIR3 EHV-1 and IR3R EHV-1,
respectively).Southern blot analyses
To conﬁrm the insertion of the zeoR and kanR markers into pRacL11
EHV-1 BAC, BamHI digested pΔIR3 EHV-1 BAC was separated on 0.3%
agarose gel and transferred onto a positively charged nylon membrane
(Ambion, Austin, TX) by using a semi-dry electroblotter (Bio-Rad
Laboratories, Hercules, CA). DNA transferred to the membrane was
placed on a piece of blot paper saturated with 0.5 M NaOH for 15 min,
brieﬂy washed with 2× SSC, and baked at 80 °C for 1 h. The PCR
fragment of the kanR [primers, 5′ taa aac atg aat gaa caa gat gga ttg cac g
3′, 5′ tta tct aga aat ctc gtg atg gca ggt tgg 3′, template, pEGFP-N1
(Clontech)] or zeoR gene [(primers, 5′ tta tct aga atc gaa atc tcg tag cac
gtg 3′, 5′ gtt aga tct tta gga gct tgt ata tcc att ttc gg 3′; template, pSVZeo2
(Invitrogen)] was end-labeled with [γ-32P]ATP (New England Nuclear
Corporation, Boston, MA) by T4 polynucleotide kinase (Promega)
according to the manufacturer's directions. Radiolabeled probe was
denatured by adding 10% 3 M NaOH for 10 min at room temperature
and then neutralized by adding an equal volume of 1 M Tris–HCl (pH
7.0). Prehybridization, hybridization and washing were performed
using the NorthernMax Kit (Ambion) followed by autoradiography
using a phosphorimage screen and the molecular imager FX system
(Bio-Rad Laboratories).Dot blot hybridization
To conﬁrm the presence of the kanR or zeoRmarker in pΔIR3 EHV-1
BAC and ΔIR3 EHV-1 genome, dot blot hybridization was performed.
pΔIR3 EHV-1 BAC DNA and total DNA that was extracted from ΔIR3
EHV-1 infected RK13 cells by using DNAzol reagent (Molecular
Research Center, Inc., Cincinnati, OH) were placed on a positively
charge nylon membrane (Ambion). DNA denaturation, hybridization
using radiolabeled kanR marker PCR product, washing, and autoradi-
ography were performed under the same conditions previously
described.Northern blot analysis
For the detection of the IR3 transcripts, the DNA probe [IR3(+443/
+728) PCR product] was radiolabeled as before. RNA samples from
EHV-1 infected RK13 cells were prepared by using RNA Bee (Tel-Test,
Inc., Friendwood, TX), separated by electrophoresis in 5% denaturing
acrylamide gel (8 M urea), and transferred to a nylon membrane
(Ambion) by using a semi-dry electroblotter (Bio-Rad Laboratories).
Prehybridization, hybridization, washing, and autoradiography were
performed as previously described.
Western blot analysis
For protein detection, RK13 cells were infectedwith RacL11 EHV-1,
IR3R EHV-1, or ΔIR3 EHV-1 at a moi of 10, and cells were harvested at
3, 6, and 12 hpi. The whole cell lysates of virus infected cells at the
immediate-early, early and late stage of replication were separated by
SDS-PAGE, and then transferred to a nitrocellulose membrane
(Ambion) by using a semi-dry electroblotter (Bio-Rad Laboratories).
The immediate-early (IE), early (IR4, EICP0, UL5), and late (gD)
proteins were detected by using anti-EHV-1 protein rabbit polyclonal
antibodies (IEP, Caughman et al., 1995; IR4P, Holden et al., 1994;
EICP0P, Bowles et al., 1997; UL5P, Zhao et al., 1995; and gDP, Flowers
and O'Callaghan, 1992) as primary antibodies and anti-rabbit IgG[Fc]-
alkaline phosphatase conjugated (Promega) as secondary antibody.
Proteins were visualized by incubating the membrane containing
blotted protein in AP conjugate substrate (AP conjugate substrate kit,
Bio-Rad Laboratories) according to manufacturer's directions. Protein
density was measured by using ImageJ software program (http://
rsbweb.nih.gov/ij/), and the relative protein density was compared.
Determination of plaque morphology, growth kinetics, and cell tropism
For the plaque assay, conﬂuent RK13 cells in 6 well plates were
infected with serial dilutions of RacL11 EHV-1, IR3R EHV-1, or ΔIR3
EHV-1. After 1 h attachment at 4 °C, virus infected cells were covered
with medium containing 1.5% methylcellulose and incubated in 5%
CO2 at 37 °C. After 4 dpi, plaques were ﬁxed with 10% formalin,
stained with 0.5% crystal violet (or methylene blue), and counted
(Perdue et al., 1974). For the comparison of plaque size, plaque sizes of
RacL11 EHV-1, IR3R EHV-1, or ΔIR3 EHV-1 in RK13 cells were
measured by using the ImageJ software program ((http://rebweb.
nih.gov/ij/). For single step growth kinetics, conﬂuent RK13 cells in
25 mm ﬂask were infected with RacL11 EHV-1 or ΔIR3 EHV-1 at a moi
of 0.1 or 5. After 1 h viral attachment at 4 °C, virus infected cells were
washed with PBS, and then 4 ml of growth medium was added. Cell
samples were harvested at designated time points followed by a
freeze and thaw cycle, and virus was titered as described above. To
determine cell tropism of ΔIR3 EHV-1, different cell types (LM, RK13,
NBL-6, Vero and HeLa cells) were infected with RacL11 EHV-1 or ΔIR3
EHV-1 at a moi of 1. After 1 h virus attachment at 4 °C, virus infected
cells were washed with cold PBS followed by adding normal growth
medium, and total viral titers were determined at 3 dpi.
Animal experiments and statistical analysis
Animal experiments were conducted as described previously
(Osterrieder et al., 1996; von Einem et al., 2004). Groups (n=12 for
mock infection, n=12 for ΔIR3 EHV-1, n=12 for IR3R EHV-1, and
n=12 for RacL11 EHV-1) of 4-week-old CBA mice were intranasally
inoculated with 2×106 pfu of ΔIR3 EHV-1 or RacL11 EHV-1; sterile
medium was inoculated as mock infection. Mice were observed daily
and weighed from prior to inoculation until 7 dpi. Virus isolation from
the lungs of dead or live mouse was performed by using silica beads
and BeadBeater (BioSpec Products, Inc., Bartlesville, OK) according to
the manufacturer's directions. Virus from lungs of mice infected with
337B.C. Ahn et al. / Virology 402 (2010) 327–337RacL11 EHV-1 (n=3), IR3R EHV-1 (n=3) or ΔIR3 EHV-1 (n=3) at 2,
3 and 4 dpi for live mice, and at the time points of death for each dead
mouse was titered as described above. For the statistical analysis to
compare body weight of mice and plaque sizes between two groups,
two-tailed Student's t test was performed by using the Excel software
program. The percent survival of mice infected with wild type or the
mutant virus was plotted, and statistical differences were analyzed by
the log-rank (Mantel-Cox) test.
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